First-in-Human Phase I Trial of Adoptive Immunotherapy with Ex Vivo Expanded and Activated Γδ T Cells Following Haploidentical Bone Marrow Transplantation and Post-BMT Cyclophospha... von Lamb, Lawrence S., Beelen, Melissa Jo, Youngblood, Samantha Langford, Soder, Rupal, Abhyankar, Sunil, McGuirk, Joseph P.

Volltext

Phase 1 trial of drug resistant immunotherapy: A first-in-class combination of MGMT-modified γδ t cells and temozolomide chemotherapy in newly diagnosed glioblastoma von Nabors, Louis B., Lamb, Lawrence S., Beelen, Melissa Jo, Pillay, Thriumaine, ter Haak, Mariska, Youngblood, Samantha, Vaickus, Louis, Lobbous, Mina

Volltext

First results from the RedirecTT-1 study with teclistamab (tec) + talquetamab (tal) simultaneously targeting BCMA and GPRC5D in patients (pts) with relapsed/refractory multiple mye... von Cohen, Yael C, Morillo, Daniel, Gatt, Moshe E, Sebag, Michael, Kim, Kihyun, Min, Chang-Ki, Oriol, Albert, Ocio, Enrique M, Yoon, Sung-Soo, Mateos, Maria-Victoria, Chu, Michael, Rodríguez-Otero, Paula, Avivi, Irit, Guo, Yue, Krevvata, Maria, Peterson, Michelle R., Beelen, Melissa Jo, Vanak, Jill, Banerjee, Arnob, Magen, Hila

Volltext